CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Integrated media group providing data-driven advertising and media solutions for global brands.	Türkiye	PCILT
PDS Biotechnology Corp Developing T-cell activating immunotherapies for cancer and infectious diseases.	United States of America	PDSB
Peers Co.,Ltd. Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.	Japan	7066
PepGen Inc. Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.	United States of America	PEPG
PeptiDream Inc. Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.	Japan	4587
Perion Network Ltd. AI-powered ad tech delivering omnichannel solutions for advertisers and publishers.	United States of America	PERI
PharmaCyte Biotech, Inc. Developing encapsulated cell therapies for targeted cancer and diabetes treatments.	United States of America	PMCB
PharmaLundensis AB Develops treatments for heavy metal toxicity and serious respiratory illnesses.	Sweden	PHAL
Pharos iBio Co., Ltd. AI-powered drug development for rare and refractory diseases, focusing on oncology.	South Korea	388870
PhoenixBio Co.,Ltd. CRO providing humanized liver mouse models and testing services for preclinical drug development.	Japan	6190